查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1704611

2025年感染疾病診斷檢測全球市場報告

Infectious Disease Diagnostics Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年感染疾病診斷檢測的市場規模將快速成長。到 2029 年，這一數字將成長至 625.8 億美元，複合年成長率為 10.1%。預測期內的成長可歸因於大流行性流感和 COVID-19 等新病原體的不斷出現、向個性化和標靶治療醫療的轉變、對快速和現場檢測解決方案的需求不斷增加、對流行病學監測和早期檢測系統的日益重視，以及專注於開發新型診斷技術和生物標記的研發活動的活性化。預測期內的關鍵趨勢包括診斷設備的小型化和便攜化、採用可同時檢測多種病原體的多重檢測、整合行動應用程式和遠端醫療平台等數位健康解決方案、採用次世代定序(NGS) 技術進行感染疾病診斷、生物感測器技術的進步以實現快速靈敏的傳染源檢測，以及將人工智慧和機器學習演算法整合到診斷平台中。

由於呼吸道感染疾病的增加，感染疾病診斷檢測市場預計將成長。呼吸道感染疾病影響呼吸系統的不同部位，是由病毒和細菌透過密切接觸、不良衛生習慣、擁擠的居住環境、季節變化等傳播引起的。感染疾病診斷檢測對於準確識別和治療呼吸道感染疾病至關重要，可以準確檢測患者樣本中的病毒和細菌等病原體。例如，加拿大衛生資訊研究所報告稱，因急性上呼吸道感染疾病住院的人數增加了 32%，從 2022 年的 2,114 例增加到 2023 年的 2,797 例。

為了保持競爭力，感染疾病診斷檢測市場的主要企業正專注於技術創新，尤其是分子診斷平台。這些平台是用於檢測和分析生物樣本中的核酸以用於診斷目的的先進系統。碧迪公司最近推出了 BD COR 系統，這是一個自動化感染疾病分子診斷平台，能夠高通量處理多達 1,700 個檢體，並在 24 小時內得出結果。該平台簡化了分子實驗室工作流程，提高了 HPV 和 STI 等疾病的診斷效率和準確性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球感染疾病診斷檢測PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球感染疾病診斷檢測市場：成長率分析
  • 全球感染疾病診斷檢測市場表現：規模與成長，2019-2024
  • 全球感染疾病診斷檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球感染疾病診斷檢測總目標市場（TAM）

第6章市場區隔

  • 全球感染疾病診斷檢測市場類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 分子診斷檢測
  • 照護現場檢驗（POCT）感染疾病診斷檢測
  • 全球感染疾病診斷檢測市場：應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 呼吸系統
  • 人類免疫力缺乏病毒（HIV）
  • 醫院相關感染疾病（HAI）
  • 性健康
  • 熱帶疾病
  • 肝
  • 全球感染疾病診斷檢測市場（按最終用戶、績效和預測）2019-2024 年、2024-2029 年、2034 年
  • 診斷實驗室
  • 醫院和診所
  • 學術研究所
  • 其他最終用戶
  • 全球感染疾病診斷檢測市場按分子診斷檢測類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素鏈鎖反應（PCR）檢測
  • 核酸增幅檢查（NAAT）
  • 次世代定序（NGS）
  • 基於微陣列的偵測
  • 全球感染疾病診斷檢測市場，依就地檢驗（POCT）感染疾病診斷檢測類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 橫向流動化驗
  • 快速抗原檢測
  • 免疫檢測
  • 可攜式PCR儀

第7章 區域和國家分析

  • 全球感染疾病診斷檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球感染疾病診斷檢測市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 感染疾病診斷檢測市場：競爭格局
  • 感染疾病診斷檢測市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Becton Dickinson And Company
  • Quest Diagnostics Incorporated
  • Grifols SA
  • Hologic Inc.
  • PerkinElmer Inc.
  • bioMerieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • DiaSorin SpA（Luminex）
  • Myriad Genetics Inc.
  • Seegene Inc.
  • Ortho Clinical Diagnostics Inc.
  • OraSure Technologies Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年感染疾病診斷檢測市場：提供新機會的國家
  • 2029年感染疾病診斷檢測市場：細分領域帶來新機會
  • 2029年感染疾病診斷檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r30473

Infectious disease diagnostics testing involves identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient's body. These tests are critical for diagnosing infectious diseases and making appropriate treatment decisions. They play a crucial role in controlling the spread of infectious diseases, guiding treatment choices, and monitoring outbreaks.

The main types of infectious disease diagnostics testing are molecular diagnostic tests and point-of-care tests (POCT) for infectious diseases. Molecular diagnostic testing refers to laboratory techniques that detect and analyze genetic material (DNA or RNA) to diagnose diseases, identify pathogens, and predict treatment responses. These tests find applications in areas such as respiratory infections, human immunodeficiency virus (HIV), healthcare-associated infections (HAIS), sexual health, tropical diseases, and liver diseases. They are utilized by various end-users including diagnostic laboratories, hospitals and clinics, academic research institutes, and other healthcare providers.

The infectious disease diagnostics testing market research report is one of a series of new reports from The Business Research Company that provides infectious disease diagnostics testing market statistics, including infectious disease diagnostics testing industry global market size, regional shares, competitors with an infectious disease diagnostics testing market share, detailed infectious disease diagnostics testing market segments, market trends, and opportunities, and any further data you may need to thrive in the infectious disease diagnostics testing industry. This infectious disease diagnostics testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The infectious disease diagnostics testing market size has grown rapidly in recent years. It will grow from $38.52 billion in 2024 to $42.56 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising disease outbreaks such as SARS, Ebola, and Zika, growing awareness among healthcare professionals and the general public about the importance of early detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, control, and prevention, increasing global travel and trade have facilitated the spread of infectious diseases, and increased healthcare spending, particularly in emerging economies.

The infectious disease diagnostics testing market size is expected to see rapid growth in the next few years. It will grow to $62.58 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the continuous emergence of novel pathogens, such as new strains of influenza or COVID-19es, the shift towards personalized medicine and targeted therapies, increasing demand for rapid and on-site testing solutions, Growing emphasis on epidemiological surveillance and early detection systems, and increased research and developments activities focused on developing novel diagnostic technologies and biomarkers. Major trends in the forecast period include miniaturization and portability of diagnostic devices, adoption of multiplex assays capable of detecting multiple pathogens simultaneously, integration of digital health solutions, such as mobile apps and telemedicine platforms, adoption of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies for rapid and sensitive detection of infectious agents, and integration of AI and machine learning algorithms into diagnostic platforms.

The infectious disease diagnostic testing market is anticipated to experience growth due to an increase in respiratory infections. Respiratory infections affect various parts of the respiratory system and are caused by viral and bacterial transmission through close contact, poor hygiene, crowded living conditions, and seasonal variations. Diagnostic testing for infectious diseases is crucial for accurate identification and treatment of respiratory infections, enabling the precise detection of pathogens such as viruses and bacteria in patient samples. For example, hospitalizations for acute upper respiratory infections saw a 32% increase from 2,114 cases in 2022 to 2,797 cases in 2023, as reported by the Canadian Institute for Health Information.

Leading companies in the infectious disease diagnostic testing market are focusing on innovation, particularly in molecular diagnostics platforms, to remain competitive. These platforms are sophisticated systems designed to detect and analyze nucleic acids from biological samples for diagnostic purposes. Becton Dickinson and Company recently launched the BD COR System, an automated infectious disease molecular diagnostics platform capable of high-throughput processing of up to 1,700 specimens with results delivered within 24 hours. This platform streamlines the molecular laboratory workflow, enhancing efficiency and diagnostic accuracy for diseases such as HPV and STIs.

In August 2022, SSI Diagnostica Group (SSID) acquired TechLab Inc., a US-based developer of infectious disease diagnostic products. This acquisition strengthens SSI Diagnostica Group's position in the infectious disease diagnostics market, aligning with their objectives of portfolio expansion, technological enhancement, and market share growth.

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease diagnostics testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease diagnostics testing market consists of revenues earned by entities by providing services such as laboratory testing, point-of-care testing, molecular diagnostics, immunoassays, and rapid diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease diagnostics testing market also includes sales of diagnostic kits, reagents, instruments, and software used for detecting and identifying infectious agents in patients. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease Diagnostics Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infectious disease diagnostics testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease diagnostics testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The infectious disease diagnostics testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Molecular Diagnostic Test; Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 2) By Application: Respiratory; Human Immunodeficiency Virus (HIV); Healthcare-Associated Infections (HAIs); Sexual Health; Tropical Diseases; Liver
  • 3) By End-User: Diagnostic Laboratories; Hospitals And Clinics; Academic Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests; Nucleic Acid Amplification Tests (NAATs); Next-Generation Sequencing (NGS); Microarray-Based Tests
  • 2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays; Rapid Antigen Tests; Immunoassays; Portable PCR
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Infectious Disease Diagnostics Testing Market Characteristics

3. Infectious Disease Diagnostics Testing Market Trends And Strategies

4. Infectious Disease Diagnostics Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Infectious Disease Diagnostics Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Infectious Disease Diagnostics Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Infectious Disease Diagnostics Testing Market Growth Rate Analysis
  • 5.4. Global Infectious Disease Diagnostics Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Infectious Disease Diagnostics Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Infectious Disease Diagnostics Testing Total Addressable Market (TAM)

6. Infectious Disease Diagnostics Testing Market Segmentation

  • 6.1. Global Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostic Test
  • Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 6.2. Global Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Respiratory
  • Human Immunodeficiency Virus (HIV)
  • Healthcare Associated Infections (HAIs)
  • Sexual Health
  • Tropical Diseases
  • Liver
  • 6.3. Global Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Laboratories
  • Hospitals And Clinics
  • Academic Research Institutes
  • Other End-Users
  • 6.4. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Molecular Diagnostic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR) Tests
  • Nucleic Acid Amplification Tests (NAATs)
  • Next-Generation Sequencing (NGS)
  • Microarray-Based Tests
  • 6.5. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Point Of Care Tests (POCT) Infectious Disease Diagnostics Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lateral Flow Assays
  • Rapid Antigen Tests
  • Immunoassays
  • Portable PCR

7. Infectious Disease Diagnostics Testing Market Regional And Country Analysis

  • 7.1. Global Infectious Disease Diagnostics Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Infectious Disease Diagnostics Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infectious Disease Diagnostics Testing Market

  • 8.1. Asia-Pacific Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infectious Disease Diagnostics Testing Market

  • 9.1. China Infectious Disease Diagnostics Testing Market Overview
  • 9.2. China Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infectious Disease Diagnostics Testing Market

  • 10.1. India Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infectious Disease Diagnostics Testing Market

  • 11.1. Japan Infectious Disease Diagnostics Testing Market Overview
  • 11.2. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infectious Disease Diagnostics Testing Market

  • 12.1. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infectious Disease Diagnostics Testing Market

  • 13.1. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infectious Disease Diagnostics Testing Market

  • 14.1. South Korea Infectious Disease Diagnostics Testing Market Overview
  • 14.2. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infectious Disease Diagnostics Testing Market

  • 15.1. Western Europe Infectious Disease Diagnostics Testing Market Overview
  • 15.2. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infectious Disease Diagnostics Testing Market

  • 16.1. UK Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infectious Disease Diagnostics Testing Market

  • 17.1. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infectious Disease Diagnostics Testing Market

  • 18.1. France Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infectious Disease Diagnostics Testing Market

  • 19.1. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infectious Disease Diagnostics Testing Market

  • 20.1. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infectious Disease Diagnostics Testing Market

  • 21.1. Eastern Europe Infectious Disease Diagnostics Testing Market Overview
  • 21.2. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infectious Disease Diagnostics Testing Market

  • 22.1. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infectious Disease Diagnostics Testing Market

  • 23.1. North America Infectious Disease Diagnostics Testing Market Overview
  • 23.2. North America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infectious Disease Diagnostics Testing Market

  • 24.1. USA Infectious Disease Diagnostics Testing Market Overview
  • 24.2. USA Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infectious Disease Diagnostics Testing Market

  • 25.1. Canada Infectious Disease Diagnostics Testing Market Overview
  • 25.2. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infectious Disease Diagnostics Testing Market

  • 26.1. South America Infectious Disease Diagnostics Testing Market Overview
  • 26.2. South America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infectious Disease Diagnostics Testing Market

  • 27.1. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infectious Disease Diagnostics Testing Market

  • 28.1. Middle East Infectious Disease Diagnostics Testing Market Overview
  • 28.2. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infectious Disease Diagnostics Testing Market

  • 29.1. Africa Infectious Disease Diagnostics Testing Market Overview
  • 29.2. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infectious Disease Diagnostics Testing Market Competitive Landscape And Company Profiles

  • 30.1. Infectious Disease Diagnostics Testing Market Competitive Landscape
  • 30.2. Infectious Disease Diagnostics Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Infectious Disease Diagnostics Testing Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson And Company
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Grifols S.A.
  • 31.4. Hologic Inc.
  • 31.5. PerkinElmer Inc.
  • 31.6. bioMerieux SA
  • 31.7. Quidel Corporation
  • 31.8. Sysmex Corporation
  • 31.9. Bio-Rad Laboratories Inc.
  • 31.10. QIAGEN N.V.
  • 31.11. DiaSorin SpA (Luminex)
  • 31.12. Myriad Genetics Inc.
  • 31.13. Seegene Inc.
  • 31.14. Ortho Clinical Diagnostics Inc.
  • 31.15. OraSure Technologies Inc.

32. Global Infectious Disease Diagnostics Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease Diagnostics Testing Market

34. Recent Developments In The Infectious Disease Diagnostics Testing Market

35. Infectious Disease Diagnostics Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Infectious Disease Diagnostics Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Infectious Disease Diagnostics Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Infectious Disease Diagnostics Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer